default search action

combined dblp search
author search
venue search
publication search

ask others

Celia C. Bojarczuk

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

Journal Articles

see FAQ

What is the meaning of the colors in the publication lists?

2004
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/artmed/BojarczukLFM04
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/artmed/BojarczukLFM04
Celia C. Bojarczuk, Heitor S. Lopes, Alex Alves Freitas, Edson L. Michalkiewicz:
A constrained-syntax genetic programming system for discovering classification rules: application to medical data sets. Artif. Intell. Medicine 30(1): 27-48 (2004)

Conference and Workshop Papers

see FAQ

What is the meaning of the colors in the publication lists?

2003
[c2]
- view
  authority control:
- export record
  dblp key:
  - conf/eurogp/BojarczukLF03
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/eurogp/BojarczukLF03
Celia C. Bojarczuk, Heitor S. Lopes, Alex Alves Freitas:
An Innovative Application of a Constrained-Syntax Genetic Programming System to the Problem of Predicting Survival of Patients. EuroGP 2003: 11-21
1999
[c1]
- no documents available
  - no references & citations available
- export record
  dblp key:
  - conf/gecco/BojarczukLF99
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/gecco/BojarczukLF99
Celia C. Bojarczuk, Heitor S. Lopes, Alex Alves Freitas:
Discovering comprehensible classification rules by using Genetic Programming: a case study in a medical domain. GECCO 1999: 953-958

Coauthor Index

see FAQ

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.